NEW YORK (AP) — Stocks that moved heavily or traded substantially Wednesday:
AstraZeneca Plc., down $1.07 to $53.64.
The drug developer halted late-stage studies of its potential COVID-19 vaccine to investigate a “potentially unexplained” illness.
Mastercard Inc., up $9.76 to $339.64.
The processor of debit and credit card payments reported higher volume in July and August.
Coupa Software Inc., down $16.22 to $260.48.
The business software company gave investors a weak third-quarter earnings forecast.
Slack Technologies Inc., down $4.08 to $25.24.
The workplace messaging service reported slower billings growth during the second quarter.
Qorvo Inc., up $8.60 to $122.71.
The chipmaker raised its profit and revenue forecasts because of growing demand for 4G and 5G mobile products.
Huntsman Corp., up 28 cents to $22.82.
The chemical company gave investors an encouraging third-quarter update as construction demand benefits its polyurethanes unit.
Intra-Cellular Therapies Inc., up $13.43 to $31.86.
The biotechnology company reported encouraging results from a study of a potential treatment for bipolar depression.
Tiffany & Co., down $7.85 to $113.96.
French luxury goods giant LVMH scrapped its $14.5 billion takeover offer for the New York jeweler.
Before you consider Qorvo, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Qorvo wasn't on the list.
While Qorvo currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
